Use of SGLT2 Inhibitors Versus DPP-4 Inhibitors and Age-Related Macular Degeneration in Patients WithType 2 Diabetes: A Multinational Cohort Study.

Pan SY, Weng CH, Tsai SF, Lin HJ, Lin JF, Lin CH, Wang IJ, Chou CC.

Open source

DOI
10.1167/iovs.66.4.58
Published
2025-04-01
Container
Invest Ophthalmol Vis Sci
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1167/iovs.66.4.58,
  title = {Use of SGLT2 Inhibitors Versus DPP-4 Inhibitors and Age-Related Macular Degeneration in Patients WithType 2 Diabetes: A Multinational Cohort Study.},
  author = {Pan SY and  Weng CH and  Tsai SF and  Lin HJ and  Lin JF and  Lin CH and  Wang IJ and  Chou CC.},
  year = {2025},
  journal = {Invest Ophthalmol Vis Sci},
  doi = {10.1167/iovs.66.4.58},
  url = {https://doi.org/10.1167/iovs.66.4.58}
}

RIS

TY  - JOUR
TI  - Use of SGLT2 Inhibitors Versus DPP-4 Inhibitors and Age-Related Macular Degeneration in Patients WithType 2 Diabetes: A Multinational Cohort Study.
AU  - Pan SY
AU  -  Weng CH
AU  -  Tsai SF
AU  -  Lin HJ
AU  -  Lin JF
AU  -  Lin CH
AU  -  Wang IJ
AU  -  Chou CC.
PY  - 2025
JO  - Invest Ophthalmol Vis Sci
DO  - 10.1167/iovs.66.4.58
UR  - https://doi.org/10.1167/iovs.66.4.58
ER  - 

APA

SY, P., CH, W., SF, T., HJ, L., JF, L., CH, L., IJ, W., & CC., C. (2025). Use of SGLT2 Inhibitors Versus DPP-4 Inhibitors and Age-Related Macular Degeneration in Patients WithType 2 Diabetes: A Multinational Cohort Study.. Invest Ophthalmol Vis Sci. https://doi.org/10.1167/iovs.66.4.58

Source records